Intermittent intravenous paracetamol versus continuous morphine in infants undergoing cardiothoracic surgery: a

Gerdien Zeilmaker-Roest1,2, Christine de Vries-Rink3,4, Joost van Rosmalen5,6

  • 1Department of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC-Sophia Children's Hospital, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands. g.zeilmaker@erasmusmc.nl.

PubMed

Insights

Intermittent intravenous (IV) paracetamol significantly reduced morphine use by 79% in young children after heart surgery. This approach provided comparable pain relief, establishing IV paracetamol as an effective primary analgesic.

Area of Science:

  • Pediatric Cardiac Surgery
  • Pain Management
  • Pharmacology

Background:

  • Postoperative pain management in children undergoing cardiac surgery with cardiopulmonary bypass often relies on opioids.
  • Morphine is a common analgesic but carries risks, necessitating exploration of alternatives.
  • Optimizing pain relief while minimizing opioid exposure is crucial for pediatric recovery.

Purpose of the Study:

  • To evaluate if intermittent intravenous (IV) paracetamol as a primary analgesic can decrease morphine consumption in children aged 0-3 years post-cardiac surgery.
  • To compare morphine requirements between patients receiving IV paracetamol and those receiving continuous morphine.
  • To assess the non-inferiority of IV paracetamol in terms of pain scores.

Main Methods:

  • A multi-center, randomized, double-blinded, controlled trial was conducted in Pediatric Intensive Care Units (PICUs).
  • Eligible children (0-3 years) received either continuous morphine or intermittent IV paracetamol after an initial morphine dose.
  • Pain was assessed using the Numeric Rating Scale (NRS), with rescue morphine administered as needed. The primary outcome was cumulative morphine dose in the first 48 hours post-surgery.

Main Results:

  • 208 children were included in the study (102 IV paracetamol, 106 continuous morphine).
  • The IV paracetamol group showed a 79% reduction in median weight-adjusted cumulative morphine consumption (145.0 mcg/kg vs. 692.6 mcg/kg; P < 0.001).
  • Non-inferiority was demonstrated for IV paracetamol regarding NRS pain scores, with no significant difference in the proportion of patients experiencing high pain scores.

Conclusions:

  • Intermittent IV paracetamol significantly reduces morphine consumption by 79% in young children following cardiac surgery.
  • IV paracetamol provides comparable pain relief to continuous morphine, establishing its role as a primary analgesic.
  • This study supports the use of IV paracetamol as a safer alternative to prolonged opioid use in pediatric cardiac surgery patients.
Abstract